Collapse of the tumor stroma is triggered by IL-12 induction of Fas.
about
Stromal Fibroblast in Age-Related Cancer: Role in Tumorigenesis and Potential as Novel Therapeutic TargetCAR T cells for solid tumors: armed and ready to go?Interleukin 12: still a promising candidate for tumor immunotherapy?Adoptive cell therapy for sarcomaNew insights into IL-12-mediated tumor suppression.Engager T cells: a new class of antigen-specific T cells that redirect bystander T cellsDendritic Cells in Irradiated Mice Trigger the Functional Plasticity and Antitumor Activity of Adoptively Transferred Tc17 Cells via IL12 SignalingAdjuvants and myeloid-derived suppressor cells: enemies or allies in therapeutic cancer vaccination.Genetically modified T-cell therapy for osteosarcomaCD8 engineered cytotoxic T cells reprogram melanoma tumor environment."Model t" cells: a time-tested vehicle for gene therapyDesign and development of therapies using chimeric antigen receptor-expressing T cellsExploiting the curative potential of adoptive T-cell therapy for cancer.CAR therapy for hematological cancers: can success seen in the treatment of B-cell acute lymphoblastic leukemia be applied to other hematological malignancies?Advanced new strategies for metastatic cancer treatment by therapeutic stem cells and oncolytic virotherapy.Repositioning therapeutic cancer vaccines in the dawning era of potent immune interventions.Adoptive immunotherapy for cancer.Genetically modified T cells to target glioblastoma.CD28z CARs and armored CARsTRUCKs: the fourth generation of CARs.Exploiting cytokines in adoptive T-cell therapy of cancer.The future of cancer treatment: immunomodulation, CARs and combination immunotherapy.Chimeric antigen receptor-engineered T cells for liver cancers, progress and obstacles.Safety and antitumor effect of oncolytic and helper-dependent adenoviruses expressing interleukin-12 variants in a hamster pancreatic cancer model.Development of CAR T cells designed to improve antitumor efficacy and safety.Anti-melanoma vaccines engineered to simultaneously modulate cytokine priming and silence PD-L1 characterized using ex vivo myeloid-derived suppressor cells as a readout of therapeutic efficacy.Prospects to improve chimeric antigen receptor T-cell therapy for solid tumors.Pro-inflammatory allogeneic DCs promote activation of bystander immune cells and thereby license antigen-specific T-cell responses.Clostridium sporogenes delivers interleukin-12 to hypoxic tumours, producing antitumour activity without significant toxicity.
P2860
Q26797288-64E2478B-EF8E-4EE6-8A13-AB7888281285Q26825489-98730B28-47EC-4276-908B-8C7A1F4D5C81Q26861559-ECB6E1FE-C43F-4EE1-A371-85B941FBEB45Q27009541-308DA4F2-44CB-4F4F-A599-3E8045A3EE72Q34436897-5A6876ED-EFAB-4608-8817-6FD78264861AQ35591391-9CCCEEB9-FD0E-40EA-BADA-EA9410AB02C7Q35674805-CDB55F37-977A-4642-A0A7-7564B5E7F9B5Q35886450-E401A59E-1E4B-4015-8961-01D8DE9A9CE3Q36198232-735D39D5-8667-4E05-BDC2-15213BA0ED53Q36821069-07E4D83E-1321-44C7-ADFB-14CEA6AD12B1Q37201423-DFD641A2-3EE6-4FDA-A84E-455602561E46Q37418289-323EB8E4-F8A2-4C07-954D-C24927969B7DQ37576033-9696AFBB-A159-44AE-82DC-CE0C01442F33Q37587956-69D67106-2343-4A32-B340-0EFF74CDB353Q37629088-7E879132-7237-4B67-B84A-B3BB174E20B3Q38149916-CF7D2E72-AF98-4FD7-94E9-E18EC6B59ECCQ38170496-E8FEC105-3035-4BAB-8162-21C0413828D6Q38178690-BC17A0E5-1B1A-44AA-B080-6F0321B50CCEQ38199347-83A709BB-A431-49AA-9314-A3460BC1B75DQ38488557-29C1CB08-5C70-4A5F-8D36-721CFB745E02Q38525044-30E4F4C8-5FD1-460A-A327-82C59D3485DEQ38775177-19280E1B-7968-482F-AF57-608D9F90EA21Q38873430-3F72438B-DF47-42C1-80F0-3B74209BCF42Q38879452-C121516A-A68B-448F-B7F7-88D5442084D2Q39200527-4B38D487-D8B6-4F00-A0FA-4E192E692868Q42124738-04D19CAD-340B-4308-88DF-624FE4DB207CQ50035774-980DD786-3299-4BA2-9E90-F24C0E4BBB78Q50535283-B67DE81E-34C7-40BF-A403-BB44DE40C783Q51701384-A30690E9-160B-4533-96A2-118E06449F68
P2860
Collapse of the tumor stroma is triggered by IL-12 induction of Fas.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Collapse of the tumor stroma is triggered by IL-12 induction of Fas.
@en
type
label
Collapse of the tumor stroma is triggered by IL-12 induction of Fas.
@en
prefLabel
Collapse of the tumor stroma is triggered by IL-12 induction of Fas.
@en
P2093
P2860
P50
P356
P1433
P1476
Collapse of the tumor stroma is triggered by IL-12 induction of Fas
@en
P2093
Anthony J Leonardi
Jenny H Pan
Joseph G Crompton
Ling Zhang
Richard A Morgan
Sid P Kerkar
Steven A Rosenberg
P2860
P304
P356
10.1038/MT.2013.58
P577
2013-04-09T00:00:00Z